Butterfly network advances medical imaging in canada with butterfly iq+

Guilford, conn. & new york--(business wire)---- $bfly--butterfly network, inc. (nyse: bfly) (“butterfly”) announced today that its second-generation iq+ has been approved for a class iii medical device license in canada. the iq+ features the world's only ultrasound-on-chip™ technology, with several hardware and software advances designed to improve usability and care delivery. “we are excited that the butterfly iq+ will now be available for purchase by canadian medical professionals,” said todd fruchterm
BFLY Ratings Summary
BFLY Quant Ranking